Arbutus Biopharma Corp (ABUS) dividend history

ABUSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3082% below fair value

$4.03+0.15 (+3.87%)

Close on Nov 12, 2026Market cap $797.33MP/E 3.6Yield –

Dividends

No dividend per share appears in Arbutus Biopharma's annual filings since fiscal 2010.

Parsed from the XBRL in Arbutus Biopharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Nov 4, 2010
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ABUS.

Revenue growth1142.6% · median 23.3%

Operating margin81.1% · median -72.7%

Net margin121.2% · median -58.8%

Advertisement
300 × 250

See a number that looks wrong?